Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Molecular analysis of a CD19-negative diffuse large B-cell lymphoma.

Delage L, Manzoni D, Quinquenet C, Fontaine J, Maarek A, Chabane K, Mosnier I, Hayette S, Callet-Bauchu E, Grange B, Plesa A, Sujobert P.

Haematologica. 2019 Mar;104(3):e114-e116. doi: 10.3324/haematol.2018.203521. Epub 2018 Dec 13. No abstract available.

2.

Helicobacter pylori prevalence and risk factors among children with celiac disease.

Maxim R, Plesa A, Stanciu C, Girleanu I, Moraru E, Trifan A.

Turk J Gastroenterol. 2018 Dec 12. doi: 10.5152/tjg.2018.18193. [Epub ahead of print]

3.

Accurate quantification of fourteen normal bone marrow cell subsets in infants to the elderly by flow cytometry.

Pont J, Souvignet A, Campos L, Plesa A, Bulabois B, Pernollet M, Raskovalova T, Dumestre-Perard C, Cesbron JY, Jacob MC.

Cytometry B Clin Cytom. 2018 Sep;94(5):627-636. doi: 10.1002/cyto.b.21643.

PMID:
30240162
4.

Total donor chimerism with bone marrow GVHD after multivisceral transplantation.

Alcazer V, Eljaafari A, Lebras L, Dubois V, Plesa A, Sobh M, Hot A, Dumortier J, Boillot O, Chambrier C, Michallet M.

Am J Hematol. 2018 Nov;93(11):E372-E374. doi: 10.1002/ajh.25253. Epub 2018 Sep 9. No abstract available.

PMID:
30113704
5.

A phase 1 study of chemosensitization with plerixafor plus G-CSF in adults with relapsed acute myeloid leukemia.

Heiblig M, Elhamri M, Thomas X, Plesa A, Raffoux E, Hayette S.

Leuk Res. 2018 Sep;72:7-11. doi: 10.1016/j.leukres.2018.07.017. Epub 2018 Jul 21. No abstract available.

PMID:
30059824
6.

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up.

Boyer T, Gonzales F, Plesa A, Peyrouze P, Barthelemy A, Guihard S, Quesnel B, Roumier C, Preudhomme C, Cheok M.

J Vis Exp. 2018 Mar 26;(133). doi: 10.3791/56976.

PMID:
29630051
7.

High frequency of CD34+CD38-/low immature leukemia cells is correlated with unfavorable prognosis in acute myeloid leukemia.

Plesa A, Dumontet C, Mattei E, Tagoug I, Hayette S, Sujobert P, Tigaud I, Pages MP, Chelghoum Y, Baracco F, Labussierre H, Ducastelle S, Paubelle E, Nicolini FE, Elhamri M, Campos L, Plesa C, Morisset S, Salles G, Bertrand Y, Michallet M, Thomas X.

World J Stem Cells. 2017 Dec 26;9(12):227-234. doi: 10.4252/wjsc.v9.i12.227.

8.

Impact-induced changes in source depth and volume of magmatism on Mercury and their observational signatures.

Padovan S, Tosi N, Plesa AC, Ruedas T.

Nat Commun. 2017 Dec 5;8(1):1945. doi: 10.1038/s41467-017-01692-0.

9.

Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma.

Landmann E, Burkhardt B, Zimmermann M, Meyer U, Woessmann W, Klapper W, Wrobel G, Rosolen A, Pillon M, Escherich G, Attarbaschi A, Beishuizen A, Mellgren K, Wynn R, Ratei R, Plesa A, Schrappe M, Reiter A, Bergeron C, Patte C, Bertrand Y.

Haematologica. 2017 Dec;102(12):2086-2096. doi: 10.3324/haematol.2015.139162. Epub 2017 Oct 5.

10.

Opsin-Mediated Inhibition of Bacterioruberin Synthesis in Halophilic Archaea.

Peck RF, Pleşa AM, Graham SM, Angelini DR, Shaw EL.

J Bacteriol. 2017 Oct 3;199(21). pii: e00303-17. doi: 10.1128/JB.00303-17. Print 2017 Nov 1.

11.

LINC01101 and LINC00277 expression levels as novel factors in HPV-induced cervical neoplasia.

Iancu IV, Anton G, Botezatu A, Huica I, Nastase A, Socolov DG, Stanescu AD, Dima SO, Bacalbasa N, Plesa A.

J Cell Mol Med. 2017 Dec;21(12):3787-3794. doi: 10.1111/jcmm.13288. Epub 2017 Aug 2.

12.

Bone Marrow Necrosis in Newly Diagnosed Acute Leukemia: Two Case Reports and Review of the Literature.

Quintela A, Sujobert P, Tigaud I, Hayette S, Ffrench M, Salles G, Thomas X, Plesa A.

Oncol Ther. 2017;5(1):111-118. doi: 10.1007/s40487-017-0041-7. Epub 2017 Feb 9.

13.

Celiac disease: past, present and future - boundless explorations of a disease of modern times.

Maxim R, Trifan A, Plesa A.

J Gastrointestin Liver Dis. 2017 Mar;26(1):92-93. doi: 10.15403/jgld.2014.1121.261.cel. No abstract available.

14.

Expression Profiling of Ribosome Biogenesis Factors Reveals Nucleolin as a Novel Potential Marker to Predict Outcome in AML Patients.

Marcel V, Catez F, Berger CM, Perrial E, Plesa A, Thomas X, Mattei E, Hayette S, Saintigny P, Bouvet P, Diaz JJ, Dumontet C.

PLoS One. 2017 Jan 19;12(1):e0170160. doi: 10.1371/journal.pone.0170160. eCollection 2017.

15.

Delta Hemolysin and Phenol-Soluble Modulins, but Not Alpha Hemolysin or Panton-Valentine Leukocidin, Induce Mast Cell Activation.

Hodille E, Cuerq C, Badiou C, Bienvenu F, Steghens JP, Cartier R, Bes M, Tristan A, Plesa A, Le VT, Diep BA, Lina G, Dumitrescu O.

Front Cell Infect Microbiol. 2016 Dec 12;6:180. doi: 10.3389/fcimb.2016.00180. eCollection 2016.

16.

Fractionated gemtuzumab ozogamicin combined with intermediate-dose cytarabine and daunorubicin as salvage therapy in very high-risk AML patients: a bridge to reduced intensity conditioning transplant?

Paubelle E, Ducastelle-Leprêtre S, Labussière-Wallet H, Nicolini FE, Barraco F, Plesa A, Salles G, Wattel E, Thomas X.

Ann Hematol. 2017 Mar;96(3):363-371. doi: 10.1007/s00277-016-2899-0. Epub 2016 Dec 23.

PMID:
28011984
17.

Flow cytometry minimal residual disease after allogeneic transplant for chronic lymphocytic leukemia.

Algrin C, Golmard JL, Michallet M, Reman O, Huynh A, Perrot A, Sirvent A, Plesa A, Salaun V, Béné MC, Bories D, Tournilhac O, Merle-Béral H, Leblond V, Le Garff-Tavernier M, Dhedin N.

Eur J Haematol. 2017 Apr;98(4):363-370. doi: 10.1111/ejh.12836. Epub 2017 Jan 30.

PMID:
27943415
18.

Comprehensive analysis of a myeloperoxidase-negative acute promyelocytic leukemia.

Heiblig M, Paubelle E, Plesa A, Geay MO, Manzoni D, Gazzo S, Tigaud I, Callet-Bauchu E, Huet S, Salles G, Thomas X, Hayette S, Sujobert P.

Blood. 2017 Jan 5;129(1):128-131. doi: 10.1182/blood-2016-09-741355. Epub 2016 Nov 8. No abstract available.

19.

This is not an osteoclast.

Plesa A, Sujobert P.

Blood. 2016 Oct 13;128(15):1993. No abstract available.

20.

PLANET TOPERS: Planets, Tracing the Transfer, Origin, Preservation, and Evolution of their ReservoirS.

Dehant V, Asael D, Baland RM, Baludikay BK, Beghin J, Belza J, Beuthe M, Breuer D, Chernonozhkin S, Claeys P, Cornet Y, Cornet L, Coyette A, Debaille V, Delvigne C, Deproost MH, De WInter N, Duchemin C, El Atrassi F, François C, De Keyser J, Gillmann C, Gloesener E, Goderis S, Hidaka Y, Höning D, Huber M, Hublet G, Javaux EJ, Karatekin Ö, Kodolanyi J, Revilla LL, Maes L, Maggiolo R, Mattielli N, Maurice M, McKibbin S, Morschhauser A, Neumann W, Noack L, Pham LB, Pittarello L, Plesa AC, Rivoldini A, Robert S, Rosenblatt P, Spohn T, Storme J-, Tosi N, Trinh A, Valdes M, Vandaele AC, Vanhaecke F, Van Hoolst T, Van Roosbroek N, Wilquet V, Yseboodt M; Planet TOPERS group (see http://iuap-planet-topers.oma.be/partners.php).

Orig Life Evol Biosph. 2016 Nov;46(4):369-384. Epub 2016 Jun 23.

PMID:
27337974
21.

Treatment patterns and comparative effectiveness in elderly acute myeloid leukemia patients (age 70 years or older): the Lyon-university hospital experience.

Heiblig M, Le Jeune C, Elhamri M, Balsat M, Tigaud I, Plesa A, Barraco F, Labussière H, Ducastelle S, Nicolini F, Wattel E, Salles G, Thomas X.

Leuk Lymphoma. 2017 Jan;58(1):110-117. Epub 2016 May 17.

PMID:
27184036
22.

Occurrence of myelodysplasia/acute myeloid leukemia 'on therapy' in two patients with acute promyelocytic leukemia.

Chelghoum Y, Plesa A, Ducastelle S, Elhamri M, Thomas X.

Indian J Cancer. 2016 Jan-Mar;53(1):59-60. doi: 10.4103/0019-509X.180843. No abstract available.

23.

The level of blast CD33 expression positively impacts the effect of gemtuzumab ozogamicin in patients with acute myeloid leukemia.

Olombel G, Guerin E, Guy J, Perrot JY, Dumezy F, de Labarthe A, Bastie JN, Legrand O, Raffoux E, Plesa A, Wagner-Ballon O, Cornet E, Salaun V, Preudhomme C, Thomas X, Pautas C, Chantepie S, Turlure P, Castaigne S, Dombret H, Feuillard J.

Blood. 2016 Apr 28;127(17):2157-60. doi: 10.1182/blood-2016-01-689976. Epub 2016 Feb 29. No abstract available.

24.

Improved outcome of children transplanted for high-risk leukemia by using a new strategy of cyclosporine-based GVHD prophylaxis.

Bleyzac N, Cuzzubbo D, Rénard C, Garnier N, Dubois V, Domenech C, Goutagny MP, Plesa A, Grardel N, Goutelle S, Janoly-Duménil A, Bertrand Y.

Bone Marrow Transplant. 2016 May;51(5):698-704. doi: 10.1038/bmt.2015.350. Epub 2016 Jan 25.

PMID:
26808568
25.

Treatment with Low-Dose Cytarabine in Elderly Patients (Age 70 Years or Older) with Acute Myeloid Leukemia: A Single Institution Experience.

Heiblig M, Elhamri M, Tigaud I, Plesa A, Barraco F, Labussière H, Ducastelle S, Michallet M, Nicolini F, Plesa C, Wattel E, Salles G, Thomas X.

Mediterr J Hematol Infect Dis. 2016 Jan 1;8(1):e2016009. doi: 10.4084/MJHID.2016.009. eCollection 2016.

26.

E5HPV16 mRNA EXPRESSION PATTERN ANALYSIS IN PATIENTS WITH CERVICAL LESIONS IN VIRAL STATUS CONTEXT.

Iancu IV, Pleşa A, Botezatu A, Huică I, Stănescu AD, Socolov D, Anton G.

Roum Arch Microbiol Immunol. 2015 Jan-Jun;74(1-2):33-9.

PMID:
26727852
27.

This is not an erythroblast.

Plesa A, Sujobert P.

Blood. 2015 Oct 1;126(14):1729. No abstract available.

28.

Comparative molecular approaches in Prader-Willi syndrome diagnosis.

Botezatu A, Puiu M, Cucu N, Diaconu CC, Badiu C, Arsene C, Iancu IV, Plesa A, Anton G.

Gene. 2016 Jan 10;575(2 Pt 1):353-8. doi: 10.1016/j.gene.2015.08.058. Epub 2015 Sep 1.

PMID:
26335514
29.

Effect of Age on Treatment Decision-Making in Elderly Patients With Acute Myeloid Leukemia.

Fattoum J, Cannas G, Elhamri M, Tigaud I, Plesa A, Heiblig M, Plesa C, Wattel E, Thomas X.

Clin Lymphoma Myeloma Leuk. 2015 Aug;15(8):477-83. doi: 10.1016/j.clml.2015.02.022. Epub 2015 Mar 5.

PMID:
25843415
30.

The p16(INK4A)/pRb pathway and telomerase activity define a subgroup of Ph+ adult Acute Lymphoblastic Leukemia associated with inferior outcome.

Chien WW, Catallo R, Chebel A, Baranger L, Thomas X, Béné MC, Gerland LM, Schmidt A, Beldjord K, Klein N, Escoffre-Barbe M, Leguay T, Huguet F, Larosa F, Hayette S, Plesa A, Ifrah N, Dombret H, Salles G, Chassevent A, Ffrench M.

Leuk Res. 2015 Apr;39(4):453-61. doi: 10.1016/j.leukres.2015.01.008. Epub 2015 Jan 25.

PMID:
25675863
31.

Metastatic carcinoid tumor--atypical presentation.

Pleşa A, Sarca E, Maxim R.

Rev Med Chir Soc Med Nat Iasi. 2014 Oct-Dec;118(4):1018-23.

PMID:
25581963
32.

Celiac disease: 10-year experience in a Romanian tertiary center.

Maxim R, Pleşa A, Ciortescu I, Gîrleanu I, Stoica O, Trifan AV.

Rev Med Chir Soc Med Nat Iasi. 2014 Oct-Dec;118(4):986-91.

PMID:
25581958
33.

Esophagectomy in esophageal cancer - is there an optimal approach?

Dănilă N, Lupaşcu C, Andronic M, Costache M, Dumitaş O, Plesa A, Blaj M, Apopei O.

Chirurgia (Bucur). 2014 Sep-Oct;109(5):600-3.

34.

Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter study.

Fossat C, Roussel M, Arnoux I, Asnafi V, Brouzes C, Garnache-Ottou F, Jacob MC, Kuhlein E, Macintyre-Davi E, Plesa A, Robillard N, Tkaczuk J, Ifrah N, Dombret H, Béné MC, Baruchel A, Garand R; French Multicenter Study Groups for Pediatric and Adult ALL.

Cytometry B Clin Cytom. 2015 Jan;88(1):21-9. doi: 10.1002/cyto.b.21195. Epub 2014 Nov 1.

35.

Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter study.

Fossat C, Roussel M, Arnoux I, Asnafi V, Brouzes C, Garnache-Ottou F, Jacob MC, Kuhlein E, Macintyre-Davi E, Plesa A, Robillard N, Tkaczuk J, Ifrah N, Dombret H, Béné MC, Baruchel A, Garand R; for the French Multicenter Study Groups for Pediatric and Adult ALL.

Cytometry B Clin Cytom. 2014 Oct 1. doi: 10.1002/cytob.21195. [Epub ahead of print]

36.

Molecular variants of human papilloma virus 16 E2, E4, E5, E6 and E7 genes associated with cervical neoplasia in Romanian patients.

Plesa A, Anton G, Iancu IV, Diaconu CC, Huica I, Stanescu AD, Socolov D, Nistor E, Popa E, Stoian M, Botezatu A.

Arch Virol. 2014 Dec;159(12):3305-20. doi: 10.1007/s00705-014-2199-8. Epub 2014 Aug 21.

PMID:
25143263
37.

SAR650984, a novel humanized CD38-targeting antibody, demonstrates potent antitumor activity in models of multiple myeloma and other CD38+ hematologic malignancies.

Deckert J, Wetzel MC, Bartle LM, Skaletskaya A, Goldmacher VS, Vallée F, Zhou-Liu Q, Ferrari P, Pouzieux S, Lahoute C, Dumontet C, Plesa A, Chiron M, Lejeune P, Chittenden T, Park PU, Blanc V.

Clin Cancer Res. 2014 Sep 1;20(17):4574-83. doi: 10.1158/1078-0432.CCR-14-0695. Epub 2014 Jul 1.

38.

Higher percentage of CD34 + CD38- cells detected by multiparameter flow cytometry from leukapheresis products predicts unsustained complete remission in acute myeloid leukemia.

Plesa A, Elhamri M, Clapisson G, Mattei E, Gazzo S, Hequet O, Tigaud I, Michallet M, Dumontet C, Thomas X.

Leuk Lymphoma. 2015 Mar;56(3):622-9. doi: 10.3109/10428194.2014.927453. Epub 2014 Jul 17.

PMID:
24884314
39.

Mobilization of CD34(+)CD38(-) hematopoietic stem cells after priming in acute myeloid leukemia.

Plesa A, Chelghoum Y, Mattei E, Labussière H, Elhamri M, Cannas G, Morisset S, Tagoug I, Michallet M, Dumontet C, Thomas X.

World J Stem Cells. 2013 Oct 26;5(4):196-204. doi: 10.4252/wjsc.v5.i4.196.

40.

Wavelet-based decomposition of high resolution surface plasmon microscopy V(Z) curves at visible and near infrared wavelengths.

Boyer-Provera E, Rossi A, Oriol L, Dumontet C, Plesa A, Berguiga L, Elezgaray J, Arneodo A, Argoul F.

Opt Express. 2013 Mar 25;21(6):7456-77. doi: 10.1364/OE.21.007456.

PMID:
23546129
41.

Bortezomib influences the expression of malignant plasma cells membrane antigens.

Tagoug I, Plesa A, Dumontet C.

Eur J Pharmacol. 2013 Apr 15;706(1-3):11-6. doi: 10.1016/j.ejphar.2013.02.002. Epub 2013 Feb 28.

PMID:
23458070
42.

Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and promoter methylation in cervical oncogenic lesions and cancer.

Botezatu A, Socolov D, Iancu IV, Huica I, Plesa A, Ungureanu C, Anton G.

J Cell Mol Med. 2013 Apr;17(4):543-9. doi: 10.1111/jcmm.12032. Epub 2013 Feb 28.

43.

High DNA methyltransferase DNMT3B levels: a poor prognostic marker in acute myeloid leukemia.

Hayette S, Thomas X, Jallades L, Chabane K, Charlot C, Tigaud I, Gazzo S, Morisset S, Cornillet-Lefebvre P, Plesa A, Huet S, Renneville A, Salles G, Nicolini FE, Magaud JP, Michallet M.

PLoS One. 2012;7(12):e51527. doi: 10.1371/journal.pone.0051527. Epub 2012 Dec 10.

44.

Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL.

Garand R, Beldjord K, Cavé H, Fossat C, Arnoux I, Asnafi V, Bertrand Y, Boulland ML, Brouzes C, Clappier E, Delabesse E, Fest T, Garnache-Ottou F, Huguet F, Jacob MC, Kuhlein E, Marty-Grès S, Plesa A, Robillard N, Roussel M, Tkaczuk J, Dombret H, Macintyre E, Ifrah N, Béné MC, Baruchel A.

Leukemia. 2013 Feb;27(2):370-6. doi: 10.1038/leu.2012.234. Epub 2012 Aug 16.

PMID:
23070018
45.

Normal levels of peripheral CD19(+) CD5(+) CLL-like cells: toward a defined threshold for CLL follow-up -- a GEIL-GOELAMS study.

Durrieu F, Geneviève F, Arnoulet C, Brumpt C, Capiod JC, Degenne M, Feuillard J, Garand R, Kara-Terki A, Kulhein E, Maynadié M, Ochoa-Noguera ME, Plesa A, Roussel M, Eghbali H, Truchan-Graczyk M, de Carvalho Bittencourt M, Feugier P, Béné MC.

Cytometry B Clin Cytom. 2011 Nov;80(6):346-53. doi: 10.1002/cyto.b.20613. Epub 2011 Oct 4.

46.

Efficacy of Helicobacter pylori eradication therapy in cirrhotic patients with peptic ulcer disease.

Mitrică D, Pleşa A, Constantinescu R, Drug V, Stanciu C.

Rev Med Chir Soc Med Nat Iasi. 2011 Apr-Jun;115(2):367-74.

PMID:
21870725
47.

Mitochondrial DNA mutations in patients with HRHPV-related cervical lesions.

Goia-Ruşanu CD, Iancu IV, Botezatu A, Socolov D, Huică I, Pleşa A, Anton G.

Roum Arch Microbiol Immunol. 2011 Jan-Mar;70(1):5-10.

PMID:
21717805
48.

Quantitative analysis of the relationship between microRNA‑124a, -34b and -203 gene methylation and cervical oncogenesis.

Botezatu A, Goia-Rusanu CD, Iancu IV, Huica I, Plesa A, Socolov D, Ungureanu C, Anton G.

Mol Med Rep. 2011 Jan-Feb;4(1):121-8. doi: 10.3892/mmr.2010.394. Epub 2010 Nov 5.

PMID:
21461574
49.

Tracking down of laryngo-pharyngeal metastasis.

Bleotu C, Popescu CR, Anton G, Pleşa A, Grigore R, Welt L, Aldea I, Draguşel R, Chivu M, Matei G, Cernescu C.

Roum Arch Microbiol Immunol. 2010 Jul-Sep;69(3):153-63.

PMID:
21434592
50.

TGF-beta signalling pathway factors in HPV-induced cervical lesions.

Iancu IV, Botezatu A, Goia-Ruşanu CD, Stănescu A, Huică I, Nistor E, Anton G, Pleşa A.

Roum Arch Microbiol Immunol. 2010 Jul-Sep;69(3):113-8.

PMID:
21434587

Supplemental Content

Support Center